SARS-CoV-2 promotes microglial synapse elimination in human brain organoids

Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.

Abstract

Neuropsychiatric manifestations are common in both the acute and post-acute phase of SARS-CoV-2 infection, but the mechanisms of these effects are unknown. In a newly established brain organoid model with innately developing microglia, we demonstrate that SARS-CoV-2 infection initiate neuronal cell death and cause a loss of post-synaptic termini. Despite limited neurotropism and a decelerating viral replication, we observe a threefold increase in microglial engulfment of postsynaptic termini after SARS-CoV-2 exposure. We define the microglial responses to SARS-CoV-2 infection by single cell transcriptomic profiling and observe an upregulation of interferon-responsive genes as well as genes promoting migration and synapse engulfment. To a large extent, SARS-CoV-2 exposed microglia adopt a transcriptomic profile overlapping with neurodegenerative disorders that display an early synapse loss as well as an increased incident risk after a SARS-CoV-2 infection. Our results reveal that brain organoids infected with SARS-CoV-2 display disruption in circuit integrity via microglia-mediated synapse elimination and identifies a potential novel mechanism contributing to cognitive impairments in patients recovering from COVID-19.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain
  • COVID-19*
  • Humans
  • Microglia
  • Organoids
  • Presynaptic Terminals
  • SARS-CoV-2*